GO:0006185 dGDP biosynthetic process: Nucleotide Metabolism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006185 describes the chemical reactions and pathways that form dGDP (2'-deoxyguanosine 5'-diphosphate), a key deoxynucleoside diphosphate in DNA metabolism.
• dGDP is generated by reduction of GDP to dGDP by ribonucleotide reductase and by phosphorylation of dGMP or deoxyguanosine, and it can be interconverted with other deoxynucleoside diphosphates by nucleoside diphosphate kinase.
• Enzymes such as NUDT5 and Deinococcus radiodurans Nudix hydrolase control dGDP levels by hydrolyzing (deoxy)ribonucleoside diphosphates, preventing mutagenic imbalances [3,8].
• dGDP is a substrate for DNA polymerases; human DNA polymerase beta can insert dGDP opposite template bases, linking dGDP pools to genome stability.
• Altered dGDP metabolism is observed in cancer, oxidative stress, and metabolic disorders, making it a target for biomarker and therapeutic studies.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in the dGDP biosynthetic process [2,4].
Description
dGDP (2'-deoxyguanosine 5'-diphosphate) is a deoxynucleoside diphosphate that serves as a direct precursor for dGTP and as a substrate for DNA polymerases during DNA synthesis and repair [1,4]. The Gene Ontology term GO:0006185, dGDP biosynthetic process, defines the chemical reactions and pathways resulting in the formation of dGDP. Understanding this process is essential because the balance of deoxynucleoside diphosphates influences mutation rates, DNA repair fidelity, and cellular responses to oxidative stress [2,3]. Research on dGDP biosynthesis spans enzymology, structural biology, and cancer metabolism. For example, nucleoside diphosphate kinase (NDK) can escalate A-to-C mutations in MutT-deficient Escherichia coli, showing that dGDP-related nucleotide pools affect mutagenesis. Human NUDT5 hydrolyzes (deoxy)ribonucleoside diphosphates, including dGDP, and its substrate specificity has been characterized structurally. In addition, human DNA polymerase beta can insert dGDP opposite template bases, directly linking dGDP availability to DNA synthesis. Because dGDP is a central node in nucleotide metabolism, researchers study its biosynthetic routes to understand diseases such as cancer, metabolic disorders, and infections. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0006185, its genes, mechanisms, and experimental models.
dGDP biosynthetic process At A Glance
| GO ID | GO:0006185 |
|---|---|
| GO term | dGDP biosynthetic process |
| Ontology | biological_process |
| Synonym | dGDP anabolism; dGDP biosynthesis; dGDP formation; dGDP synthesis |
| Definition | The chemical reactions and pathways resulting in the formation of dGDP, deoxyguanosine diphosphate, (2'-deoxyguanosine 5'-diphosphate). |
| Major function | Production of dGDP for DNA synthesis, repair, and deoxynucleotide pool maintenance [1,4]. |
| Related enzymes | Ribonucleotide reductase, nucleoside diphosphate kinase, NUDT5, Nudix hydrolases [2,3,8]. |
| Related diseases | Cancer, oxidative stress-related mutagenesis, metabolic disorders [2,6]. |
What Is GO:0006185?
GO:0006185 (dGDP biosynthetic process) is the biological process comprising the chemical reactions and pathways that produce dGDP, deoxyguanosine diphosphate (2'-deoxyguanosine 5'-diphosphate). It includes enzymatic steps that convert guanine-containing precursors into dGDP, such as reduction of GDP to dGDP or phosphorylation of dGMP, and it is part of the broader deoxyribonucleotide biosynthetic network [1,2].
Why Is dGDP biosynthetic process Important in Cell Biology?
dGDP biosynthesis is important because dGDP is a direct precursor of dGTP and a substrate for DNA polymerases, so its production must be tightly regulated to maintain genome stability [1,4]. Imbalances in deoxynucleoside diphosphate pools can increase mutation rates, as shown by NDK-driven A-to-C mutations in MutT-deficient E. coli. Enzymes that hydrolyze dGDP, such as NUDT5 and Nudix hydrolases, prevent such imbalances and are linked to oxidative stress responses [3,8]. Therefore, studying GO:0006185 helps explain mechanisms of mutagenesis, cancer metabolism, and potential therapeutic targets.
• dGDP is a direct precursor for dGTP, which is required for DNA replication and repair [1,4].
• Nucleoside diphosphate kinase can interconvert dGDP with other deoxynucleoside diphosphates, affecting mutation rates.
• NUDT5 and Nudix hydrolases control dGDP levels by hydrolysis, protecting against mutagenic imbalances [3,8].
• Human DNA polymerase beta can insert dGDP opposite template bases, linking dGDP pools to DNA synthesis fidelity.
• dGDP metabolism is relevant to cancer biology and metabolic disorders, as indicated by serum metabolomics studies.
• Oxidation of dGDP by platinum(IV) complexes shows that dGDP is chemically reactive and can form adducts.
• dGDP is a target for structural and mechanistic studies of nucleotide-binding enzymes [4,8].
• Understanding dGDP biosynthesis can inform development of anticancer and antimicrobial agents [2,6].
What Happens During dGDP biosynthetic process?
Reduction of GDP to dGDP
In simple terms: A ribose sugar on GDP is converted to deoxyribose, making dGDP.
The first major route to dGDP is the reduction of GDP by ribonucleotide reductase, which removes the 2'-hydroxyl group from the ribose moiety to produce the deoxyribonucleotide. This step is part of the de novo deoxyribonucleotide biosynthetic pathway and is essential for providing dGDP for DNA synthesis [1,4].
Phosphorylation of dGMP or deoxyguanosine
In simple terms: dGDP can also be made by adding a phosphate group to dGMP or by phosphorylating deoxyguanosine.
dGDP can be generated through phosphorylation of dGMP by nucleoside diphosphate kinase or other kinases, or via phosphorylation of deoxyguanosine to dGMP and then to dGDP. Nucleoside diphosphate kinase catalyzes the transfer of a phosphate group from a donor nucleotide to dGDP, interconverting deoxynucleoside diphosphates.
Interconversion by nucleoside diphosphate kinase
In simple terms: An enzyme called NDK can swap phosphates between different deoxynucleotides, including dGDP.
Nucleoside diphosphate kinase (NDK) catalyzes the reversible transfer of a phosphate group between nucleoside triphosphates and nucleoside diphosphates, thereby interconverting dGDP with other deoxynucleoside diphosphates. In MutT-deficient E. coli, NDK activity escalates A-to-C mutations, demonstrating that dGDP pool imbalances can drive mutagenesis.
Hydrolysis and quality control by Nudix hydrolases
In simple terms: Enzymes like NUDT5 and Nudix hydrolases break down dGDP to keep its levels balanced.
Nudix hydrolases, such as human NUDT5 and a Deinococcus radiodurans Nudix hydrolase, hydrolyze (deoxy)ribonucleoside 5'-diphosphates including dGDP [3,8]. NUDT5 shows diverse substrate recognition and hydrolysis mechanisms, and its activity helps prevent accumulation of mutagenic deoxynucleoside diphosphates. This hydrolysis is a quality-control step that opposes dGDP biosynthesis and maintains nucleotide pool homeostasis [3,8].
Insertion of dGDP by DNA polymerases
In simple terms: DNA polymerases can use dGDP as a building block, but mistakes can cause mutations.
Human DNA polymerase beta can insert dGDP opposite template bases, as shown by mechanistic studies. This insertion links dGDP availability directly to DNA synthesis and repair, and misinsertion can contribute to mutagenesis if dGDP levels are imbalanced.
Key Genes Involved in GO:0006185 dGDP biosynthetic process
The following genes and proteins are experimentally linked to dGDP biosynthesis, its regulation, or its utilization in DNA metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NME1 (NDK) | Nucleoside diphosphate kinase; interconverts dGDP with other deoxynucleoside diphosphates | Mutagenesis studies in MutT-deficient E. coli; cancer metastasis research |
| NUDT5 | Hydrolyzes (deoxy)ribonucleoside diphosphates including dGDP | Structural and mechanistic studies of substrate recognition |
| NUDT1 (MutT) | Hydrolyzes oxidized guanine nucleotides; prevents A-to-C mutations | Mutator phenotype studies; oxidative stress response |
| POLB | DNA polymerase beta; can insert dGDP opposite template bases | DNA repair fidelity and mutagenesis research |
| RRM1 | Ribonucleotide reductase subunit; reduces GDP to dGDP | Deoxynucleotide biosynthesis and cancer therapy |
| RRM2 | Ribonucleotide reductase subunit; reduces GDP to dGDP | Cell cycle regulation and DNA synthesis |
| D. radiodurans Nudix hydrolase | Hydrolyzes (deoxy)ribonucleoside 5'-diphosphates with marked specificity | Radiation resistance and nucleotide pool studies |
| GUK1 | Guanylate kinase; phosphorylates dGMP to dGDP | Nucleotide metabolism and antiviral research |
| AK1 | Adenylate kinase; may contribute to nucleotide diphosphate interconversion | Energy metabolism and nucleotide pool studies |
| NT5C | 5'-nucleotidase; dephosphorylates nucleotides, affecting dGDP precursors | Nucleotide catabolism research |
| ITPA | Inosine triphosphate pyrophosphatase; maintains nucleotide pool purity | Mutagenesis and drug toxicity studies |
| GART | Phosphoribosylglycinamide formyltransferase; de novo purine synthesis | Purine biosynthesis and cancer metabolism |
| PAICS | Phosphoribosylaminoimidazole carboxylase; purine biosynthesis | Metabolic flux studies |
| ATIC | AICAR transformylase; purine biosynthesis | Purine metabolism and disease models |
| IMPDH1 | Inosine monophosphate dehydrogenase; GMP synthesis | GMP/dGDP precursor supply |
| IMPDH2 | Inosine monophosphate dehydrogenase; GMP synthesis | Cancer and immunosuppression research |
| GMPS | GMP synthase; converts XMP to GMP | Guanylate biosynthesis |
| NME2 | Nucleoside diphosphate kinase; interconverts dGDP | Transcription regulation and nucleotide metabolism |
How Is dGDP biosynthetic process Regulated?
dGDP biosynthesis is regulated at multiple levels. Ribonucleotide reductase activity is controlled by cell cycle and allosteric feedback by deoxynucleoside triphosphates, ensuring balanced dGDP production. Nucleoside diphosphate kinase interconverts dGDP with other deoxynucleoside diphosphates, and its activity can escalate mutations when nucleotide pools are imbalanced. Nudix hydrolases such as NUDT5 and the Deinococcus radiodurans Nudix hydrolase hydrolyze dGDP, providing a counter-regulatory mechanism to prevent accumulation [3,8]. In addition, oxidative stress can alter dGDP levels and oxidation products, as shown by platinum(IV) complex oxidation studies.
dGDP biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NME1 | Cancer metastasis and mutagenesis | Knockout in cancer cell lines; mutation reporter assays |
| NUDT5 | Oxidative stress and nucleotide pool imbalance | Knockout and overexpression in HEK293 cells |
| POLB | DNA repair deficiency and mutagenesis | Point mutation knock-in in POLB locus |
| RRM1 | Cancer proliferation and drug resistance | Knockout and overexpression in tumor models |
| NUDT1 (MutT) | Mutator phenotype and oxidative stress | Knockout in E. coli and mammalian cells |
dGDP biosynthesis and cancer metabolism
Altered deoxynucleotide metabolism is a hallmark of cancer, and dGDP biosynthesis supports the high DNA synthesis rates of proliferating tumor cells [1,6]. Serum metabolomics has identified biomarkers in radicular cysts, indicating that nucleotide metabolites including dGDP-related species can reflect disease states. Targeting ribonucleotide reductase and other dGDP biosynthetic enzymes is a strategy in anticancer drug development.
dGDP imbalance and mutagenesis
Imbalances in dGDP pools can increase mutation rates. In MutT-deficient E. coli, nucleoside diphosphate kinase escalates A-to-C mutations, linking dGDP interconversion to mutagenesis. Human DNA polymerase beta can insert dGDP opposite template bases, and misinsertion may contribute to DNA damage and genomic instability. NUDT5 and Nudix hydrolases help prevent such imbalances by hydrolyzing dGDP [3,8].
Oxidative stress and dGDP oxidation
dGDP can be oxidized by platinum(IV) complexes, forming adducts that may affect nucleotide function. This reactivity suggests that dGDP is sensitive to oxidative stress, which is relevant to neurodegenerative and inflammatory diseases [1,6]. Nudix hydrolases such as NUDT5 may protect against oxidized dGDP derivatives.
From dGDP biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NUDT5 alter dGDP levels? | CRISPR knockout of NUDT5 in HEK293 or HeLa cells |
| Does a point mutation in POLB affect dGDP insertion? | Point mutation knock-in of POLB catalytic residues |
| Can dGDP biosynthetic enzymes be tagged for localization? | Knock-in of fluorescent tags at RRM1 or NME1 loci |
| Does overexpression of NME1 increase mutation rates? | Overexpression of NME1 in MutT-deficient cells |
| Which genes regulate dGDP pool size? | CRISPR library screening targeting nucleotide metabolism genes |
| Does dGDP imbalance affect DNA repair? | Knockout of NUDT5 combined with DNA damage agents |
How to Study the dGDP biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | dGDP and related nucleotide levels | Biomarker discovery in disease models |
| Enzymatic assay with recombinant NUDT5 | dGDP hydrolysis rate | Substrate specificity studies |
| X-ray crystallography | Three-dimensional structure of dGDP-bound enzymes [4,8] | Mechanistic studies of DNA polymerase beta and NUDT5 |
| Mutation reporter assay | A-to-C mutation frequency | Mutagenesis studies in MutT-deficient E. coli |
| HPLC nucleotide analysis | Separation and quantification of dGDP | Nudix hydrolase substrate profiling |
| CRISPR knockout screening | Gene essentiality in dGDP metabolism | Identification of regulators of dGDP pools |
| Western blot | Protein expression of NME1, NUDT5, POLB [2,8] | Validation of knockout or overexpression |
| Fluorescence microscopy | Subcellular localization of tagged enzymes | Knock-in tagged cell lines |
Metabolomics and nucleotide quantification
Mass spectrometry-based metabolomics can quantify dGDP and related nucleotides in cells and tissues. Serum metabolomics has been used to identify biomarkers in radicular cysts, demonstrating the utility of this approach for dGDP-related studies.
Enzymatic assays for dGDP biosynthesis
In vitro enzymatic assays using recombinant ribonucleotide reductase, nucleoside diphosphate kinase, or NUDT5 can measure dGDP production or hydrolysis [2,3,8]. These assays typically use radiolabeled or fluorescent nucleotide substrates and HPLC separation [3,8].
Structural biology and mechanistic studies
X-ray crystallography and NMR can reveal how enzymes such as NUDT5 and DNA polymerase beta recognize dGDP [4,8]. Structural studies of NUDT5 have shown diverse substrate recognition and hydrolysis mechanisms.
Mutagenesis and reporter assays
Mutation reporter assays in E. coli or mammalian cells can link dGDP pool imbalances to A-to-C mutations. The MutT-deficient E. coli model is particularly useful for studying NDK-driven mutagenesis.
How CRISPR Can Be Used to Study GO:0006185 dGDP biosynthetic process
Knockout
CRISPR knockout of genes such as NUDT5, NME1, or RRM1 can reveal their roles in dGDP biosynthesis and pool maintenance [2,8]. For example, knocking out NUDT5 may increase dGDP levels and affect DNA repair. Knockout of NME1 in MutT-deficient E. coli can test its role in A-to-C mutagenesis.
Point Mutation
Point mutation knock-in can model catalytic residues or regulatory phosphorylation sites in enzymes like POLB or NUDT5 [4,8]. For instance, mutating the catalytic site of POLB can test its ability to insert dGDP. Point mutations in NUDT5 can dissect substrate recognition.
Knock-in
Knock-in of fluorescent or affinity tags at endogenous loci allows visualization and purification of dGDP biosynthetic enzymes. Tagging RRM1 or NME1 can help track their localization and interactions.
Overexpression
Overexpression of NME1 or NUDT5 can test whether increased enzyme levels alter dGDP pools and mutation rates [2,8]. Overexpression of POLB can assess dGDP insertion frequency.
How EDITGENE Supports dGDP biosynthetic process Research
Researchers studying dGDP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in dGDP production, DNA synthesis, or mutagenesis. EDITGENE provides CRISPR-based cell models and screening services to enable such causal experiments.
Contact EDITGENE today to design your custom CRISPR model for dGDP biosynthetic process research.
Frequently Asked Questions About dGDP biosynthetic process
What is dGDP biosynthetic process?
dGDP biosynthetic process (GO:0006185) is the set of chemical reactions and pathways that produce dGDP, a deoxynucleoside diphosphate used in DNA synthesis.
What genes are involved in dGDP biosynthetic process?
Genes include NME1 (NDK), NUDT5, POLB, RRM1, RRM2, and NUDT1 (MutT), among others [1,2,4,8].
How is dGDP made in cells?
dGDP is made by reduction of GDP by ribonucleotide reductase or by phosphorylation of dGMP or deoxyguanosine [1,2].
What enzymes regulate dGDP levels?
Nucleoside diphosphate kinase interconverts dGDP, while NUDT5 and Nudix hydrolases hydrolyze it to maintain balance [2,3,8].
Why is dGDP important for DNA synthesis?
dGDP is a direct precursor of dGTP and can be inserted by DNA polymerases such as POLB during DNA synthesis and repair.
Can dGDP imbalance cause mutations?
Yes, in MutT-deficient E. coli, nucleoside diphosphate kinase escalates A-to-C mutations, showing that dGDP pool imbalance is mutagenic.
What diseases are linked to dGDP metabolism?
Cancer, oxidative stress-related mutagenesis, and metabolic disorders have been linked to altered dGDP metabolism [1,2,6].
How can I study dGDP biosynthetic process with CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can test the roles of NUDT5, NME1, POLB, and other genes [2,4,8].
What methods measure dGDP levels?
LC-MS metabolomics, HPLC, and enzymatic assays with recombinant enzymes are commonly used [3,6,8].
Does EDITGENE provide services for dGDP research?
Yes, EDITGENE offers knockout, point mutation, knock-in, overexpression, CRISPR library screening, and bioinformatics services for dGDP-related genes [2,4,6,8].
Conclusion
GO:0006185 (dGDP biosynthetic process) is a central node in deoxynucleotide metabolism, supplying dGDP for DNA synthesis and repair while requiring tight regulation to prevent mutagenesis [1,2,4]. Key enzymes such as ribonucleotide reductase, nucleoside diphosphate kinase, NUDT5, and DNA polymerase beta have been characterized in mechanistic and structural studies [2,4,8]. Dysregulation of dGDP metabolism is linked to cancer, oxidative stress, and metabolic disorders, making it a promising area for therapeutic and biomarker research [1,6]. CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, provide powerful tools to dissect the causal roles of dGDP-related genes [2,4,8]. EDITGENE supports these efforts with custom cell model generation, library screening, and bioinformatics services to accelerate discovery in nucleotide metabolism.
References
- 1. Kipouros I et al.. 2015. Oxidation of 5'-dGMP, 5'-dGDP, and 5'-dGTP by a platinum(IV) complex.. J Biol Inorg Chem 20(8):1327-41 PMID: 26588933
- 2. Kapoor I et al.. 2019. Nucleoside Diphosphate Kinase Escalates A-to-C Mutations in MutT-Deficient Strains of Escherichia coli.. J Bacteriol 202(1) PMID: 31591275
- 3. Fisher DI et al.. 2004. Characterization of a nudix hydrolase from Deinococcus radiodurans with a marked specificity for (deoxy)ribonucleoside 5'-diphosphates.. BMC Biochem 5:7 PMID: 15147580
- 4. Varela FA et al.. 2021. Mechanism of Deoxyguanosine Diphosphate Insertion by Human DNA Polymerase β.. Biochemistry 60(5):373-380 PMID: 33475337
- 6. Wei Z et al.. 2025. Serum metabolomics identifies biomarkers in radicular cysts.. Metabolomics 22(1):5 PMID: 41324827
- 8. Arimori T et al.. 2011. Diverse substrate recognition and hydrolysis mechanisms of human NUDT5.. Nucleic Acids Res 39(20):8972-83 PMID: 21768126
